Science, Technology & Innovation

Disruptive innovation is a priority for anyone seeking growth in today’s investment climate. Milltrust clients receive privileged access to thoroughly vetted opportunities across a range of risk/return profiles.


Welcome to British Innovation

The British Innovation Fund

Despite British universities being consistently high in global rankings, Britain has historically struggled to raise sufficient capital to commercialise its world-class research. The British Innovation Fund supplies capital to support early stage spin out companies forming as a result of this research. The Fund invests into leading British University spinout companies emanating from these Universities.


The British Innovation Fund recognises the world-class science and technology development that is being carried out in many of Britain’s top universities. The Fund nurtures impactful, early-stage companies – helping them reach their full potential and guiding them to world-wide recognition and success.


The Fund carefully picks spinout companies from its network of universities as well as the established, in-house university commercialisation companies which the Fund is in close contact with – spinout companies that demonstrate a viable commercial business, have unique patented IP and have technology with platform capability. This significantly reduces investment risks and enhances the probability of outsized returns for investors.


1. Academics bring promising IP and commercially reliable ideas to the attention of university technology transfer offices (“TTO”) and university commercialisation companies
2. TTOs provide funding and support to the most promising opportunities which are spun out as individual companies, with further investment from the experienced technologists and venture capitalist at the university commercialisation companies
3. Investment opportunities are shared with the team at the British Innovation Fund through their relationships with TTOs and the commercialisation companies
4. Enhanced due diligence, including scientific validation from specialists and review by the investment advisory committee, is conducted prior to deployment of capital from the British Innovation Fund.



The British Innovation Fund actively seeks to maximize its alignment to the UN Sustainable Development Goals (SDGs), which were adopted by all United Nations Member States in 2015 as a universal call to action to end poverty, protect the planet and ensure that all people enjoy peace and prosperity by 2030. Achieving the SDGs requires the partnership of governments, private sector, civil society and citizens alike to make sure we leave a better planet for future generations. The fund’s primary SDG alignment focus is on:

Fund Terms

Fund profile

Platform:Milltrust International Managed Investments ICAV
Investment Manager:Milltrust International LLP
Investment Adviser:Milltrust Agricultural Investments Ltd
Structure:Open-ended Investment Company
Strategy:Commercialisation of research emerging out of UK universities
Domicile:Dublin, Ireland
Inception Date:25 November 2016
Share Classes:Class (A), Class (B), Class (C), Class (D)
Management Fee:2%
Performance Fee:20% over Hurdle Rate
Hurdle Rate:8%
Subscription Terms:10 years
Investor Types:For Professional and Accredited Investors Only
Registered for Distribution in:United Kingdom, Ireland

Service Providers

Administrator:MUFG Alternative Fund Services (Ireland) Ltd.
Custodian:Mitsubishi UFJ Investor Services & Banking (Luxembourg) S.A.
Legal:William Fry

CerraCap II LP

CerraCap II LP


CerraCap II SP is a Global fund dedicated to early-stage technology investments. The fund focuses on Enterprise (B2B) products and solutions in the emerging technology areas of Healthcare, AI and Cyber Security.

The fund reduces investment risk by maintaining one strategy since inception; targeting great teams with high growth characteristics. CerraCap makes great management better by personally introducing companies to Fortune 500 decision-makers. The team calls this model Sales and Scale where they industrialize innovation.

CerraCap II SP  is a sub-fund of CerraCap International Investments SPC, registered in the Cayman Islands, and is managed by Epithauma LLC. The fund is a feeder into a US master fund, Cerracap II LP.

Key Features


Investment Team

The fund is managed by CerraCap Ventures, headquartered in California with operations out of global hubs of tech innovation (San Francisco, Tel Aviv, and Bangalore).

The team at CerraCap Ventures are former UST Global execs from California, with a past track record returning a stellar 9x return since inception.

CerraCap Ventures also boasts a phenomenal advisory board including Vicente Fox, former President of Mexico, John C. Cushman, Chairman of Cushman & Wakefield, Richard P Crane Jr., Lawyer and Member of U.S. Department of Justice, and our own Simon Hopkins, amongst others





INCEPTION: 29/11/2016


Milltrust International LLP

6 Stratton Street
London W1J 8LD
United Kingdom
Tel: +44 (0)20 8123 8369
Email: [email protected]

Milltrust International Group (Singapore) Pte Ltd

77B Tras Street
Singapore 078978
Tel: +65 6225 3052
Fax: +65 6225 3072
Email: [email protected]


Milltrust International Managed Investments ICAV

The offering documents for the Milltrust International Managed Investments ICAV are only available to residents of the European Union, as follows:

1. To persons who qualify as a “Professional client” in accordance with Annex II of the Directive 2014/65/EU (Markets in Financial Instruments Directive), as may be amended, replaced, supplemented or novated.

The following qualify as professional clients:

· Entities which are required to be authorised or regulated to operate in the financial markets:

(a) Credit institutions

(b) Investment firms

(c) Other authorised or regulated financial institutions

(d) Insurance companies

(e) Collective investment schemes and management companies of such schemes

(f) Pension funds and management companies of such funds

(g) Commodity and commodity derivatives dealers

(h) Other institutional investors

· Large undertakings meeting two of the following size requirements on a company basis:

(a) balance sheet total: EUR 20 000 000

(b) net turnover: EUR 40 000 000

(c) own funds: EUR 2 000 000

· National and regional governments, public bodies that manage public debt, Central Banks, international and supranational institutions such as the World Bank, the IMF, the ECB, the EIB and other similar international organisations.

· Other institutional investors whose main activity is to invest in financial instruments.

I/We hereby certify that I/we am/are a professional client as defined above.

2. To persons who have received an appraisal from an EU credit institution, a MiFID firm or a UCITS management company that they have the appropriate expertise, experience and knowledge to adequately understand the potential investment in the Milltrust International Managed Investments ICAV.

I/We hereby certify that I/we am/are an investor who has received an appraisal as set out above.

I/We hereby indemnify and hold harmless Milltrust International Managed Investments ICAV, Milltrust International LLP, any other member of the group of entities owned by Milltrust International Group (Singapore) Pte. Ltd. and their respective directors, members, partners, agents, officers and anyone acting on their behalf from and against all damages, losses, costs and expenses (including, without limitation, reasonable attorneys’ fees) which they may incur by reason of any material breach of the above representations and warranties made by me/us.